Paternal age and Down syndrome in British Columbia.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMC 1684867)

Published in Am J Hum Genet on January 01, 1981

Authors

E B Hook, P K Cross, S H Lamson, R R Regal, P A Baird, S H Uh

Articles by these authors

Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev (1995) 5.71

The value of capture-recapture methods even for apparent exhaustive surveys. The need for adjustment for source of ascertainment intersection in attempted complete prevalence studies. Am J Epidemiol (1992) 3.65

An epidemiologic study of congenital malformations of the anterior abdominal wall in more than half a million consecutive live births. Am J Hum Genet (1981) 3.19

Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use. Am J Hum Genet (1977) 2.75

Spontaneous deaths of fetuses with chromosomal abnormalities diagnosed prenatally. N Engl J Med (1978) 2.66

Maternal age-specific rates of 47,+21 and other cytogenetic abnormalities diagnosed in the first trimester of pregnancy in chorionic villus biopsy specimens: comparison with rates expected from observations at amniocentesis. Am J Hum Genet (1988) 2.38

The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum Genet (1983) 2.29

Estimated rates of Down syndrome in live births by one year maternal age intervals for mothers aged 20-49 in a New York State study-implications of the risk figures for genetic counseling and cost-benefit analysis of prenatal diagnosis programs. Birth Defects Orig Artic Ser (1977) 2.28

Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic. Pediatrics (1990) 2.18

Effect of variation in probability of ascertainment by sources ("variable catchability") upon "capture-recapture" estimates of prevalence. Am J Epidemiol (1993) 2.13

Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol (1981) 2.11

Behavioral implications of the human XYY genotype. Science (1973) 2.02

Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA (1983) 1.95

Down syndrome in live births by single year maternal age interval in a Swedish study: comparison with results from a New York State study. Am J Hum Genet (1978) 1.94

Rates of mutant and inherited structural cytogenetic abnormalities detected at amniocentesis: results on about 63,000 fetuses. Ann Hum Genet (1987) 1.89

Goodness-of-fit based confidence intervals for estimates of the size of a closed population. Stat Med (1984) 1.84

Paternal age and the risk of birth defects in offspring. Epidemiology (1995) 1.81

Chromosome abnormalities and spontaneous fetal death following amniocentesis: further data and associations with maternal age. Am J Hum Genet (1983) 1.79

Birth defects among offspring of firemen. Am J Epidemiol (1990) 1.78

Folic acid: abortifacient or pseudoabortifacient? Am J Med Genet (2000) 1.69

The natural history of cytogenetically abnormal fetuses detected at midtrimester amniocentesis which are not terminated electively: new data and estimates of the excess and relative risk of late fetal death associated with 47,+21 and some other abnormal karyotypes. Am J Hum Genet (1989) 1.69

The effects of prenatal diagnosis, population ageing, and changing fertility rates on the live birth prevalence of Down syndrome in New York State, 1983-1992. Prenat Diagn (1996) 1.68

Multiple sclerosis: updated risks for relatives. Am J Med Genet (1988) 1.67

Capture-recapture methods. Lancet (1992) 1.67

Report of the Task Force on Teaching Human Genetics in North American Medical Schools. Am J Hum Genet (1989) 1.65

Differences between rates of trisomy 21 (Down syndrome) and other chromosomal abnormalities diagnosed in livebirths and in cells cultured after second-trimester amniocentesis--suggested explanations and implications for genetic counseling and program planning. Birth Defects Orig Artic Ser (1978) 1.61

Cigarette smoking and Down syndrome. Am J Hum Genet (1985) 1.59

A cost-benefit analysis of prenatal detection of Down syndrome and neural tube defects in older mothers. Am J Med Genet (1981) 1.57

Frequency of Down syndrome in livebirths by single-year maternal age interval: results of a Massachusetts study. Teratology (1978) 1.56

Apparent "in situ" clone of cytogenetically marked ataxia-telangiectasia lymphocytes. Humangenetik (1975) 1.56

Early in vitro division of PHA stimulated cord blood lymphocytes: implications for study of chromosome breakage. Am J Hum Genet (1976) 1.56

Parental age and unbalanced Robertsonian translocations associated with Down syndrome and Patau syndrome: comparison with maternal and paternal age effects for 47, +21 and 47, +13. Ann Hum Genet (1984) 1.54

Rates of trisomies 21, 18, 13 and other chromosome abnormalities in about 20 000 prenatal studies compared with estimated rates in live births. Hum Genet (1982) 1.53

Cardiovascular birth defects and antenatal exposure to female sex hormones. N Engl J Med (1977) 1.53

Mental retardation in over half-a-million consecutive livebirths: an epidemiological study. Am J Ment Defic (1985) 1.50

Neural tube rupture as a cause of neural tube defects. Lancet (1992) 1.50

Normal or affected controls in case-control studies of congenital malformations and other birth defects: reporting bias issues. Epidemiology (1993) 1.47

Maternal age and Down syndrome: age-specific incidence rates by single-year intervals. Am J Med Genet (1978) 1.45

Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med (1991) 1.45

Statistical and logical considerations in evaluating the association of prenatal folic-acid supplementation with pregnancy loss. Am J Med Genet (2001) 1.41

Validity of methods for model selection, weighting for model uncertainty, and small sample adjustment in capture-recapture estimation. Am J Epidemiol (1997) 1.41

Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets. Prenat Diagn (1998) 1.41

Hirschsprung disease in a large birth cohort. Teratology (1985) 1.38

Cytogenetic and epidemiological findings in Down syndrome, England and Wales 1989 to 1993. National Down Syndrome Cytogenetic Register and the Association of Clinical Cytogeneticists. J Med Genet (1996) 1.37

Measuring birth defects and handicapping disorders in the population: the British Columbia Health Surveillance Registry. CMAJ (1987) 1.35

Limb reduction defects in over one million consecutive livebirths. Teratology (1989) 1.33

Death certificate reports of cardiovascular disorders in children: comparison with diagnoses in a pediatric cardiology registry. J Chronic Dis (1977) 1.33

Rates of mutant structural chromosome rearrangements in human fetuses: data from prenatal cytogenetic studies and associations with maternal age and parental mutagen exposure. Am J Hum Genet (1983) 1.32

The frequency of 47,+21,47,+18, and 47,+13 at the uppermost extremes of maternal ages: results on 56,094 fetuses studied prenatally and comparisons with data on livebirths. Hum Genet (1984) 1.31

Cerebral gigantism: endocrinological and clinical observations of six patients including a congenital giant, concordant monozygotic twins, and a child who acheived adult gigantic size. J Pediatr (1967) 1.30

Recommendations for presentation and evaluation of capture-recapture estimates in epidemiology. J Clin Epidemiol (1999) 1.28

Down's syndrome: percentage reporting on birth certificates and single year maternal age risk rates for Ohio 1970-79: comparison with upstate New York data. Am J Public Health (1981) 1.25

Congenital anomalies of the central nervous system incidence in British Columbia, 1952-72. Teratology (1978) 1.25

Muddling genetic discrimination. Am J Hum Genet (1992) 1.24

Estimates of maternal age-specific risks of Down-syndrome birth in women aged 34-41. Lancet (1976) 1.23

Inherited ring chromosomes: an analysis of published cases. Hum Genet (1991) 1.23

Amelia: incidence and associated defects in a large population. Teratology (1990) 1.22

Risks of unbalanced progeny at amniocentesis to carriers of chromosome rearrangements: data from United States and Canadian laboratories. Am J Med Genet (1989) 1.22

Paternal age and the risk of congenital heart defects. Teratology (1994) 1.20

Unbalanced Robertsonian translocations associated with Down's syndrome or Patau's syndrome: chromosome subtype, proportion inherited, mutation rates, and sex ratio. Hum Genet (1981) 1.20

Life expectancy in Down syndrome. J Pediatr (1987) 1.19

Congenital asymmetry associated with trisomy 18 mosaicism. Am J Dis Child (1965) 1.18

Decreased HLA heterogeneity in parents of children with Down syndrome. Am J Hum Genet (1983) 1.15

Incidence and prevalence as measures of the frequency of birth defects. Am J Epidemiol (1982) 1.15

Genetic distinctions are not necessarily examples of genetic discrimination. Am J Hum Genet (1992) 1.15

Neural tube defects in the Sikhs. Am J Med Genet (1983) 1.14

A simple function for maternal-age-specific rates of Down syndrome in the 20-to-49-year age range and its biological implications. Am J Hum Genet (1980) 1.13

Rates of Down's syndrome in live births and at midtrimester amniocentesis. Lancet (1978) 1.11

Reproductive hazards and the workplace. CMAJ (1992) 1.09

The imprecision in rates of Down syndrome by 1-year maternal age intervals: a critical analysis of rates used in biochemical screening. Prenat Diagn (1994) 1.09

Nausea and vomiting of pregnancy and association with pregnancy outcome. Am J Obstet Gynecol (1986) 1.09

Massachusetts Department of Public Health. Use of prenatal cytogenetic diagnosis in New York State. N Engl J Med (1981) 1.09

Temporal increase in the rate of Down syndrome livebirths to older mothers in New York State. J Med Genet (1981) 1.09

Rates of Down syndrome at livebirth by one-year maternal age intervals in studies with apparent close to complete ascertainment in populations of European origin: a proposed revised rate schedule for use in genetic and prenatal screening. Am J Med Genet (1996) 1.08

Amniotic band sequence and limb defects: data from a population-based study. Am J Med Genet (1993) 1.08

Renal agenesis in British Columbia. Am J Med Genet (1985) 1.08

Validity of Bernoulli census, log-linear, and truncated binomial models for correcting for underestimates in prevalence studies. Am J Epidemiol (1982) 1.08

Extra structurally abnormal chromosomes (ESAC) detected at amniocentesis: frequency in approximately 75,000 prenatal cytogenetic diagnoses and associations with maternal and paternal age. Am J Hum Genet (1987) 1.07

The familial nature of multiple sclerosis: age-corrected empiric recurrence risks for children and siblings of patients. Neurology (1988) 1.06

Accuracy of alternative approaches to capture-recapture estimates of disease frequency: internal validity analysis of data from five sources. Am J Epidemiol (2000) 1.06

Dietary cravings and aversions during pregnancy. Am J Clin Nutr (1978) 1.05

Some epidemiological aspects of Down's syndrome in British Columbia. Br J Prev Soc Med (1968) 1.05

Case ascertainment for state-based birth defects registries: characteristics of unreported infants ascertained through birth certificates and their impact on registry statistics in New York state. Paediatr Perinat Epidemiol (1996) 1.05

Rates of trisomy 18 in livebirths, stillbirths, and at amniocentesis. Birth Defects Orig Artic Ser (1979) 1.04

Use of capture-recapture analyses in fetal alcohol syndrome surveillance in Alaska. Am J Epidemiol (1995) 1.03

False-positive reporting of Down syndrome on Ohio and New York birth certificates. Genet Epidemiol (1985) 1.03